Mitchell Schnall
Senior Vice President for Data and Technology Solutions at Penn Medicine; Professor of Radiology and former Chair of the Radiology Department at the Perelman School of Medicine
About
Dr. Mitchell D. Schnall is an international leader in translational biomedical and imaging research, working throughout his career across the interface between basic imaging science and clinical medicine to ensure effective integration of radiology research with other medical disciplines. His work has led to fundamental changes in the imaging approaches to breast and prostate cancer, and he continues to have a significant influence on emerging imaging technologies, including those in optical imaging.
Dr. Schnall has played a critical role in efforts to organize cancer clinical and translational imaging research in the US. He has been the principal investigator of numerous team science initiatives. In 2008 he assumed the role of ACRIN Chair. Among the important trials ACRIN completed under his leadership is the landmark National Lung Cancer Screening trial that demonstrated the ability of low dose lung cancer screening to reduce lung cancer mortality by 20% in high risk patients. Dr. Schnall was one of the architects of the merger of ECOG and ACRIN to form the new ECOG-ACRIN Cancer Research Group, which he now co-Chairs.
Dr. Schnall has been elected as a member of the American Society for Clinical Investigation, the Association of American Physicians and the Institute of Medicine of the National Academy of Sciences (now the National Academy of Medicine).